Among all patients with a BMI of 25.0 kg/m 2 , the mean percent weight loss from the index date was 13.4% at 6 months, 17.6% at 12 months, and more than 20% at 18 and 24 months
Safety profiling of GLP-1 therapy Studies have found that GLP-1 agonists are associated with increased risk of gastrointestinal adverse events spanning from nausea and vomiting to pancreatitis and kidney dysfunction
Whether you choose Calibrate, Found, or explore compounded GLP-1 options through PlexusDx, integrating genetic and biomarker context into your decision process may enhance personalization
Mucuna pruriens (Velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1B9 Drosophila melanogaster genetic model of Parkinsons disease
While semaglutide is highly effective, it may not be suitable for everyone
Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al